» Articles » PMID: 10560362

Pseudomonas Aeruginosa Pyocyanin and 1-hydroxyphenazine Inhibit Fungal Growth

Overview
Journal J Clin Pathol
Specialty Pathology
Date 1999 Nov 24
PMID 10560362
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To examine strains of Pseudomonas aeruginosa for specific antifungal factors.

Methods: Two clinical strains of P aeruginosa with strong in vitro inhibition (by cross streak assay) of Candida albicans and Aspergillus fumigatus were examined. Both strains were isolated from sputum--one from a patient with cystic fibrosis and one from a patient with bronchiectasis. Bacterial extracts were fractionated by high performance liquid chromatography and examined by ultraviolet absorbance and mass spectroscopy. Antifungal activity against C albicans and A fumigatus was determined in a well plate assay.

Results: Pyocyanin was the major antifungal agent of P aeruginosa; 1-hydroxy-phenazine also possessed activity. Pyocyanin MICs for C albicans and A fumigatus were > 64 micrograms/ml. These phenazines were active against nine other yeast species pathogenic for man. Preliminary experiments also suggested possible inhibition of yeast mycelial transformation in C albicans by pyocyanin.

Conclusions: There may be a role for pyocyanin and 1-hydroxyphenazine in the prevention of pulmonary candidiasis in patients colonised by P aeruginosa.

Citing Articles

A Comprehensive Review on Bioactive Molecules and Advanced Microorganism Management Technologies.

Wali A, Talath S, Sridhar S, Shareef J, Goud M, Rangraze I Curr Issues Mol Biol. 2024; 46(11):13223-13251.

PMID: 39590383 PMC: 11592628. DOI: 10.3390/cimb46110789.


Anti-Fungal () Activity of in Cystic Fibrosis Synthetic Sputum.

Sass G, Kethineni S, Stevens D Pathogens. 2024; 13(10).

PMID: 39452746 PMC: 11510391. DOI: 10.3390/pathogens13100875.


Antimicrobial mechanisms and antifungal activity of compounds generated by banana rhizosphere Gxun-2 against f. sp. .

Lu J, Huang Y, Liu R, Liang Y, Zhang H, Shen N Front Microbiol. 2024; 15:1456847.

PMID: 39386368 PMC: 11461210. DOI: 10.3389/fmicb.2024.1456847.


Production and Antibacterial Activity of Atypical Siderophore from sp. QCS59 Recovered from .

Almuhawish M, Kotb E, Alkhaldi E, Ahmed A Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338291 PMC: 11434927. DOI: 10.3390/ph17091126.


Intestinal immunity in C. elegans is activated by pathogen effector-triggered aggregation of the guard protein TIR-1 on lysosome-related organelles.

Tse-Kang S, Wani K, Peterson N, Page A, Humphries F, Pukkila-Worley R Immunity. 2024; 57(10):2280-2295.e6.

PMID: 39299238 PMC: 11464196. DOI: 10.1016/j.immuni.2024.08.013.


References
1.
Hughes W, Kim H . Mycoflora in cystic fibrosis: some ecologic aspects of Pseudomonas aeruginosa and Candida albicans. Mycopathol Mycol Appl. 1973; 50(3):261-9. DOI: 10.1007/BF02053377. View

2.
Costa A, Cusumano V . [Anti-mycotic acitivity of pyocyanine in vitro and in vivo on a pathogenic strain of Candida albicans]. G Batteriol Virol Immunol Microbiol. 1973; 66(7-12):297-308. View

3.
Knight M, Hartman P, Hartman Z, YOUNG V . A new method of preparation of pyocyanin and demonstration of an unusual bacterial sensitivity. Anal Biochem. 1979; 95(1):19-23. DOI: 10.1016/0003-2697(79)90179-9. View

4.
Wilson R, Sykes D, WATSON D, Rutman A, Taylor G, COLE P . Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun. 1988; 56(9):2515-7. PMC: 259599. DOI: 10.1128/iai.56.9.2515-2517.1988. View

5.
Wilson R, Pitt T, Taylor G, WATSON D, MacDermot J, Sykes D . Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest. 1987; 79(1):221-9. PMC: 424027. DOI: 10.1172/JCI112787. View